Literature DB >> 3927296

Deletion of a B-cell-specific enhancer affects transfected, but not endogenous, immunoglobulin heavy-chain gene expression.

D M Zaller, L A Eckhardt.   

Abstract

A transcriptional enhancer has recently been identified between the variable and constant region coding segments of an assembled immunoglobulin heavy-chain gene. This enhancer is required for efficient expression of such genes when transfected into myeloma cells. A class switch rearrangement in the mouse myeloma cell line 9.9.2.1 has resulted in deletion of this enhancer, and yet this cell line continues to produce heavy chains at a high level. Cell line 9.9.2.1 is a gamma 2a-producing class-switch variant derived from the gamma 2b-producing myeloma cell line, MPC11. We demonstrate that despite the high level of heavy-chain production in 9.9.2.1, the cloned 9.9.2.1 heavy-chain gene is not expressed efficiently when transfected into myeloma cells. Efficient expression after transfection can be obtained only if the deleted enhancer is reinserted into the gene. The implication of this finding for the role of this enhancer in establishing and/or maintaining immunoglobulin heavy-chain gene expression is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3927296      PMCID: PMC390504          DOI: 10.1073/pnas.82.15.5088

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  High-frequency transfer of cloned herpes simplex virus type 1 sequences to mammalian cells by protoplast fusion.

Authors:  R M Sandri-Goldin; A L Goldin; M Levine; J C Glorioso
Journal:  Mol Cell Biol       Date:  1981-08       Impact factor: 4.272

2.  Independent immunoglobulin class-switch events occurring in a single myeloma cell line.

Authors:  L A Eckhardt; B K Birshtein
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

3.  A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes.

Authors:  J Banerji; L Olson; W Schaffner
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

4.  Expression of immunoglobulin heavy chain at a high level in the absence of a proposed immunoglobulin enhancer element in cis.

Authors:  M R Wabl; P D Burrows
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

5.  Immunoglobulin heavy-chain enhancer requires one or more tissue-specific factors.

Authors:  M Mercola; J Goverman; C Mirell; K Calame
Journal:  Science       Date:  1985-01-18       Impact factor: 47.728

6.  DNA rearrangements in MPC-11 immunoglobulin heavy chain class-switch variants.

Authors:  L A Eckhardt; S A Tilley; R B Lang; K B Marcu; B K Birshtein
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

7.  Immunoglobulin gene expression in transformed lymphoid cells.

Authors:  V T Oi; S L Morrison; L A Herzenberg; P Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

8.  Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells.

Authors:  M S Neuberger
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

9.  Deletion of the IgH enhancer does not reduce immunoglobulin heavy chain production of a hybridoma IgD class switch variant.

Authors:  S Klein; F Sablitzky; A Radbruch
Journal:  EMBO J       Date:  1984-11       Impact factor: 11.598

10.  Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. I. Adaptation of the Merwin plasma cell tumor-11 to culture, cloning, and characterization of gamma globulin subunits.

Authors:  R Laskov; M D Scharff
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

View more
  32 in total

1.  Functional analysis of the murine IgH enhancer: evidence for negative control of cell-type specificity.

Authors:  T Kadesch; P Zervos; D Ruezinsky
Journal:  Nucleic Acids Res       Date:  1986-10-24       Impact factor: 16.971

2.  Immunoglobulin heavy-chain enhancer is required to maintain transfected gamma 2A gene expression in a pre-B-cell line.

Authors:  B Porton; D M Zaller; R Lieberson; L A Eckhardt
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

3.  Activation of immunoglobulin control elements in transgenic mice.

Authors:  A E Miller; D L Ennist; K Ozato; H Westphal
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

4.  An element in the endogenous IgH locus stimulates gene targeting in hybridoma cells.

Authors:  A Buzina; M J Shulman
Journal:  Nucleic Acids Res       Date:  1996-04-15       Impact factor: 16.971

5.  The rat albumin promoter is composed of six distinct positive elements within 130 nucleotides.

Authors:  P Herbomel; A Rollier; F Tronche; M O Ott; M Yaniv; M C Weiss
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

6.  In vitro transcription of immunoglobulin genes in a B-cell extract: effects of enhancer and promoter sequences.

Authors:  R Sen; D Baltimore
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

7.  Strong transcriptional activation of translocated c-myc genes occurs without a strong nearby enhancer or promoter.

Authors:  E Kakkis; M Mercola; K Calame
Journal:  Nucleic Acids Res       Date:  1988-01-11       Impact factor: 16.971

8.  Random isolation of gene activator elements from the human genome.

Authors:  H Hamada
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

9.  Recombination and transcription of the endogenous Ig heavy chain locus is effected by the Ig heavy chain intronic enhancer core region in the absence of the matrix attachment regions.

Authors:  E Sakai; A Bottaro; L Davidson; B P Sleckman; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  Transcription of a productively rearranged Ig VDJC alpha does not require the presence of HS4 in the IgH 3' regulatory region.

Authors:  Buyi Zhang; Adrienne Alaie-Petrillo; Maria Kon; Fubin Li; Laurel A Eckhardt
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.